511 Therapeutics
Cambridge, US · Founded 2022 · Delaware corporation
Find your way into 511 Therapeutics
Sign up to see every warm intro you have to 511 Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 511 Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SZ
Shuguang ZhangNamed on SEC filing
YL
Yancen LuNamed on SEC filing
UB
Uwe B. SleytrNamed on SEC filing
AM
Andrew MarshallNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$550K disclosed across 2 rounds · 2022–2026
▶$500KraisedOct 2026 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedOct 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shuguang ZhangExecutive Officer, Director
- Yancen LuDirector
- Uwe B. SleytrDirector
- Andrew MarshallExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- Oct 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$50KraisedOct 2022 · 1 investors · BiotechnologyRule 506(b)
▶$50KraisedOct 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shuguang ZhangExecutive Officer, Director
- Yancen LuDirector
- Uwe B. SleytrDirector
- Offering amount
- $600K
- Amount sold
- $50K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has 511 Therapeutics raised?
- 511 Therapeutics has disclosed $550K raised across 2 rounds.
- Where is 511 Therapeutics headquartered?
- 511 Therapeutics is headquartered in Cambridge, US.